Last updated on May 2019

A Long-Term Registry of Humira (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Brief description of study

This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.

Clinical Study Identifier: NCT01848561

Find a site near you

Start Over

Attleboro Gastroenterology, PC /ID# 113899

Attleboro, MA United States
  Connect »